Gestala Raises $21.6 Million in Angel Funding
Gestala, a Chinese startup focused on developing non-invasive ultrasound-based brain-computer interface (BCI) technology, has raised $21.6 million in its angel funding round. The investment was led by Guosheng Capital and Dalton Venture, with additional participation from Tsing Song Capital, Gobi Ventures, Fourier Intelligence, Liepin, and Seas Capital.
A New Player in the BCI Industry
Founded by Phoenix Peng, a serial entrepreneur and neuroscientist, Gestala aims to revolutionize the BCI sector by providing a non-invasive approach to interacting with neural activity. Unlike traditional methods that require implanted devices, Gestala's technology utilizes ultrasound to enable communication with the brain, potentially offering broader and safer applications in medical treatments and neurological research.
Strategic Use of Funds
The newly secured funds will be primarily allocated to research and development efforts, as well as to conducting pivotal clinical trials. According to Peng, the company plans to expand its team from 15 to approximately 35 employees by the end of the year. Additionally, part of the funding will be used to establish a manufacturing facility in China, which is crucial for scaling up production as the company seeks to complete its first-generation prototype by year-end.
Lead Investors and Their Vision
The funding round was notably co-led by Guosheng Capital and Dalton Venture, with significant interest from other investors, marking it as one of the largest angel rounds in China's BCI industry. The round was heavily oversubscribed, indicating strong investor confidence in Gestala’s innovative approach and potential market impact.
Future Prospects
Gestala's approach aligns with a growing global interest in BCI technologies, as companies and research institutions explore new methods for enabling direct communication between the human brain and external devices. By focusing on scalable and non-invasive neurotechnology systems, Gestala aims to expand the boundaries of neuroscience and artificial intelligence research.
Phoenix Peng, Gestala's founder and CEO, expressed optimism about the future, stating that the ultrasound-based systems could represent the next generation of BCI technology. "Ultrasound offers the potential for broader, whole-brain access and new ways to interact with neural activity," Peng noted.
With this significant funding round, Gestala is well-positioned to make substantial advancements in the BCI field, potentially setting new standards for how humans interact with technology through the power of the mind.